A Molecularly Imprinted Membrane for High-Density Lipoprotein Extraction in Point-of-Care Testing.

Cholesterol blood levels in low-density lipoproteins (LDLs) are a key parameter for assessing the risk of cardiovascular diseases. Direct quantification of LDL cholesterol at the point of care would be possible if all other lipoproteins, particularly the high-density lipoproteins (HDLs), could be removed prior to measurement. Here, we investigated whether a molecularly imprinted membrane (MIM) could be used for the solid-phase affinity extraction (SPAE) of HDL in a paper-based lateral flow test. Samples traveled by capillarity through the MIM before reaching a detection zone where LDL cholesterol was quantified enzymatically. MIMs were produced by impregnation of the membrane with a dispersion of molecularly imprinted polymers (MIPs) selective for HDL. MIPs were synthesized using precipitation polymerization and exhibited good selectivity for HDL compared with LDL and an uptake capacity of 5.0-7.0 µg of HDL-C/mg of MIP. The MIM enabled the removal of HDL with an efficiency of typically 68%. However, quantification of LDL cholesterol suffered from strong non-specific binding of LDL, likely due to its inherent colloidal instability. Overall, our results highlight the challenges associated with SPAE of colloidal particles. Furthermore, our study demonstrates a novel, efficient, and potentially generic modality to integrate SPAE into paper-based POC diagnostic tests.